Enablex and Skelaxin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Enablex (darifenacin hydrobromide) and Skelaxin (metaxalone). Common drug interactions include hyperglycaemia among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Enablex and Skelaxin. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.
What is Enablex?
Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.
What is Skelaxin?
Skelaxin has active ingredients of metaxalone. It is often used in back pain. eHealthMe is studying from 9,706 Skelaxin users. Check the latest studies of Skelaxin.
25 people who take Enablex and Skelaxin together, and have interactions are studied.

What are the common drug interactions of Enablex and Skelaxin, by gender? *:
female:
- Hyperglycaemia (high blood sugar)
- Insomnia (sleeplessness)
- Nausea (feeling of having an urge to vomit)
- Pneumonia
- Psychomotor hyperactivity (feelings of extreme restlessness)
- Sleep disorder
- Tardive dyskinesia (a disorder that involves involuntary movements)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Type 2 diabetes mellitus
- Blood pressure increased
male:
- Anaemia (lack of blood)
- Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
- Back disorder
- Hip arthroplasty
- Memory impairment
- Nausea (feeling of having an urge to vomit)
What are the common drug interactions of Enablex and Skelaxin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
- Hyperglycaemia (high blood sugar)
- Insomnia (sleeplessness)
- Sleep disorder
- Type 2 diabetes mellitus
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Vision blurred
40-49:
- Cough
- Injection site haemorrhage (bleeding from injection site)
- Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
- Nasal discomfort
- Sinusitis (inflammation of sinus)
- Throat irritation
50-59:
- Cellulitis (infection under the skin)
- Chest pain
- Confusional state
- Fatigue (feeling of tiredness)
- Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
- Confusional state
- Dry mouth
- Headache (pain in head)
- Hypertension (high blood pressure)
- Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light)
- Nail disorder (disease of nail)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Nausea (feeling of having an urge to vomit)
- Oesophageal stenosis (narrowing of oesophagus)
- Pneumonia
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 24.00%
- Pain: 5 people, 20.00%
- Depression: 5 people, 20.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 16.00%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 12.00%
- High Blood Cholesterol: 3 people, 12.00%
- Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 12.00%
- Abdominal Discomfort: 3 people, 12.00%
- Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 2 people, 8.00%
- Muscle Tightness: 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Enablex and Skelaxin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Enablex and Skelaxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Enablex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Skelaxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Enablex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Skelaxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on darifenacin hydrobromide and metaxalone (the active ingredients of Enablex and Skelaxin, respectively), and Enablex and Skelaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dupixent cause Sunburn? - 8 seconds ago
- Drug interactions of Cardizem and Excedrin - 9 seconds ago
- Carcinoid Tumor and Dementia Alzheimer'S Type - 9 seconds ago
- Drug interactions of Bupivacaine and Chloramphenicol - 9 seconds ago
- Drug interactions of Tecfidera and Copaxone - 21 seconds ago
- Drug interactions of Digoxin and Ketamine Hydrochloride - 30 seconds ago
- Could Calcium cause Ligament Rupture? - 35 seconds ago
- Could Sodium Ascorbate cause Drowsiness? - 39 seconds ago
- Could Insulin cause Pathological Fracture? - 48 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Valproate Sodium - 49 seconds ago